T he weight-loss drug Zepbound (tirzepatide) now has another major benefit: on Dec. 20, it became the first drug approved by ...
The study found that 62% of study participants with sleep apnea who received peer support used the CPAP machine correctly and consistently, compared with 51% of those who only received educational ...
The study found that 62% of study participants with sleep apnea who received peer support used the CPAP machine correctly and consistently, compared with 51% of those who only received educational ...
If you have sleep apnea and obesity, Zepbound may offer relief and support weight loss. Ask your doctor if it’s a good fit for your treatment plan.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback